HF Advisory Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
HF Advisory Group's ELV Position: Q3 2026 in Review
HF Advisory Group reduced its Elevance Health (ELV) stake by 13% in Q3 2026, selling an estimated $342K and leaving 5,923 shares worth $2.3M. The position accounts for 0.69% of the portfolio, ranked #55.
HF Advisory Group first reported a position in ELV in Q4 2022 and has held it in 16 quarters since. The position peaked at $2.62M in Q2 2026. 399 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- HF Advisory Group held 5,923 shares of Elevance Health worth $2.3M as of Q3 2026.
- HF Advisory Group sold 858 Elevance Health shares in Q3 2026, an estimated $342K.
- Elevance Health made up 0.69% of HF Advisory Group's portfolio in Q3 2026, its #55 holding.
- HF Advisory Group first reported a position in Elevance Health in Q4 2022 and has held it in 16 quarters since.
- HF Advisory Group's Elevance Health position peaked at $2.62M in Q2 2026.
- 399 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on HF Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.